Clinical Trials Logo

Clinical Trial Summary

This study is a prospective, randomized, placebo-controlled, double-blind trial to determine the effect of high concentrate omega-3 capsules on the omega-3 status of patients with non-alcoholic fatty liver.


Clinical Trial Description

Subjects with non-alcoholic fatty liver (simple steatosis) confirmed within the last year by ultrasound or other imaging modality will be recruited to the study. Subjects will be randomized to a treatment arm of high concentrate capsules or placebo for a 6 month treatment period.Omega-3 content of red blood cells (omega-3 index) will be measured for primary endpoint assessment. Quantitative MRI will be performed to determine the effect on liver fat content. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02923804
Study type Interventional
Source Pronova BioPharma
Contact
Status Completed
Phase N/A
Start date October 2015
Completion date December 1, 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03625284 - Oral Dietary Fucoxanthin Rich Supplement for Liver Health N/A
Completed NCT03222206 - The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease Phase 4
Completed NCT04823676 - Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management N/A
Completed NCT03186859 - Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease) N/A
Completed NCT02030977 - The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis Phase 2/Phase 3
Recruiting NCT06176079 - Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Not yet recruiting NCT06138821 - ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial Phase 4
Not yet recruiting NCT04553796 - Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
Not yet recruiting NCT03801577 - Hepaxa Management of Non-alcoholic Fatty Liver Disease N/A
Completed NCT05804422 - Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) N/A
Recruiting NCT04625166 - Combi-elastography Assessment of Chronic Liver Disease Multi-center Study
Recruiting NCT05523024 - Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL. N/A
Not yet recruiting NCT05822622 - Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.